Patents by Inventor JOY L. KOVAR

JOY L. KOVAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200179514
    Abstract: The present invention relates to compositions and methods for destroying target cells in a patient using photodynamic therapy. In particular, the present invention provides a photosensitizing agent based on a small molecular weight (<50 kDa) protein or peptide or a small molecule that is conjugated to a phthalocyanine dye, such as IRDye® 700DX.
    Type: Application
    Filed: January 24, 2020
    Publication date: June 11, 2020
    Applicant: LI-COR, INC.
    Inventor: JOY L. KOVAR
  • Patent number: 10588972
    Abstract: The present invention relates to compositions and methods for destroying target cells in a patient using photodynamic therapy. In particular, the present invention provides a photosensitizing agent based on a small molecular weight (<50 kDa) protein or peptide or a small molecule that is conjugated to a phthalocyanine dye, such as IRDye® 700DX.
    Type: Grant
    Filed: June 2, 2015
    Date of Patent: March 17, 2020
    Assignee: LI-COR, INC.
    Inventor: Joy L. Kovar
  • Publication number: 20150374819
    Abstract: The present invention relates to compositions and methods for destroying target cells in a patient using photodynamic therapy. In particular, the present invention provides a photosensitizing agent based on a small molecular weight (<50 kDa) protein or peptide or a small molecule that is conjugated to a phthalocyanine dye, such as IRDye® 700DX.
    Type: Application
    Filed: June 2, 2015
    Publication date: December 31, 2015
    Applicant: LI-COR, INC.
    Inventor: Joy L. Kovar
  • Publication number: 20150343060
    Abstract: The present invention relates to methods and compositions for eliminating circulating tumor cells (CTCs) in a patient with or without solid tumors. In particular, the ex vivo method utilizes a photodynamic or magnetic targeting moiety that specifically binds to antigens expressed on the cell surface of CTCs.
    Type: Application
    Filed: June 2, 2015
    Publication date: December 3, 2015
    Applicant: LI-COR, INC.
    Inventors: JOY L. KOVAR, HAN-WEI WANG